CU20120041A7 - Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen - Google Patents
Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienenInfo
- Publication number
- CU20120041A7 CU20120041A7 CU2012000041A CU20120041A CU20120041A7 CU 20120041 A7 CU20120041 A7 CU 20120041A7 CU 2012000041 A CU2012000041 A CU 2012000041A CU 20120041 A CU20120041 A CU 20120041A CU 20120041 A7 CU20120041 A7 CU 20120041A7
- Authority
- CU
- Cuba
- Prior art keywords
- oxazolobenzodiazepinonas
- dihidro
- derivatives
- new
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Abstract
Compuestos de fórmula (I): en la que: R1 representa un átomo de hidrógeno o un grupo alquilo; R2 representa un grupo alquilo; R3 representa un grupo arilo o heteroarilo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1100682A FR2972454B1 (fr) | 2011-03-08 | 2011-03-08 | Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20120041A7 true CU20120041A7 (es) | 2013-10-29 |
CU24134B1 CU24134B1 (es) | 2015-11-27 |
Family
ID=44004482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CUP2012000041A CU24134B1 (es) | 2011-03-08 | 2012-03-08 | Nuevos derivados dihidro-oxazolobenzodiazepinonas, y las composiciones farmacéuticas que los contienen |
Country Status (44)
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230684B1 (en) | 2014-01-21 | 2017-08-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
DE102016005291B4 (de) | 2016-04-29 | 2024-01-11 | Ksg Austria Gmbh | Verfahren zur Herstellung eines elektronischen Gerätes in der Form eines Spritzgußteils mit eingelegter Leiterplatte |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0101223B1 (en) | 1982-08-06 | 1987-04-01 | Ube Industries, Ltd. | process for producing phenylacetones |
US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
UA67749C2 (uk) * | 1997-08-12 | 2004-07-15 | Егіш Дьйодьсердьяр Рт. | Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування |
PL338681A1 (en) * | 1997-08-12 | 2000-11-20 | Egyt Gyogyszervegyeszeti Gyar | Derivatives of 1,3-dioxolo/4,5-h/2,3-benzodiazepins as inhibitors of ampa/cainate receptors |
GB9900222D0 (en) * | 1999-01-06 | 1999-02-24 | Merck Sharp & Dohme | Therapeutic compounds |
HU227128B1 (en) * | 1999-07-07 | 2010-07-28 | Egyt Gyogyszervegyeszeti Gyar | New 2,3-benzodiazepine derivatives |
JP2009513644A (ja) * | 2005-10-26 | 2009-04-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 治療組成物および方法 |
HU230760B1 (hu) * | 2005-12-30 | 2018-03-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Dihidro-2,3-benzodiazepin-származékok optikai izomerjei, eljárás ezek sztereoszelektív szintézisére, alkalmazásuk, az ezeket tartalmazó gyógyszerkészítmények és az eljárás közbenső termékei |
EP2298296A1 (en) * | 2009-08-25 | 2011-03-23 | CNRS Centre National De La Recherche Scientifique | Composition and method for treating cognitive impairments in down syndrome subjects |
-
2011
- 2011-03-08 FR FR1100682A patent/FR2972454B1/fr active Active
-
2012
- 2012-02-20 IL IL218215A patent/IL218215A/en active IP Right Grant
- 2012-02-21 JO JO201236A patent/JO2948B1/en active
- 2012-02-22 PE PE2012000242A patent/PE20121682A1/es active IP Right Grant
- 2012-02-22 SG SG2012012340A patent/SG184633A1/en unknown
- 2012-02-22 AU AU2012201031A patent/AU2012201031B2/en not_active Ceased
- 2012-02-24 MY MYPI2012700036A patent/MY162537A/en unknown
- 2012-02-27 CL CL2012000496A patent/CL2012000496A1/es unknown
- 2012-02-28 UY UY0001033927A patent/UY33927A/es unknown
- 2012-03-02 MA MA34658A patent/MA33641B1/fr unknown
- 2012-03-05 CA CA2771189A patent/CA2771189C/fr not_active Expired - Fee Related
- 2012-03-05 GE GEAP201212613A patent/GEP20146017B/en unknown
- 2012-03-06 MX MX2012002788A patent/MX2012002788A/es active IP Right Grant
- 2012-03-06 CR CR20120109A patent/CR20120109A/es unknown
- 2012-03-06 EC ECSP12011711 patent/ECSP12011711A/es unknown
- 2012-03-06 AP AP2012006149A patent/AP3344A/xx active
- 2012-03-07 PL PL12290077T patent/PL2497774T3/pl unknown
- 2012-03-07 PT PT122900772T patent/PT2497774E/pt unknown
- 2012-03-07 NZ NZ598625A patent/NZ598625A/xx not_active IP Right Cessation
- 2012-03-07 ES ES12290077.2T patent/ES2442293T3/es active Active
- 2012-03-07 SI SI201230017T patent/SI2497774T1/sl unknown
- 2012-03-07 RS RS20130492A patent/RS53032B/en unknown
- 2012-03-07 JP JP2012050550A patent/JP5475816B2/ja not_active Expired - Fee Related
- 2012-03-07 DK DK12290077.2T patent/DK2497774T3/da active
- 2012-03-07 HN HN2012000485A patent/HN2012000485A/es unknown
- 2012-03-07 NI NI201200039A patent/NI201200039A/es unknown
- 2012-03-07 BR BRBR102012005137-0A patent/BR102012005137A2/pt not_active Application Discontinuation
- 2012-03-07 AR ARP120100728A patent/AR085691A1/es unknown
- 2012-03-07 EA EA201200267A patent/EA021125B1/ru not_active IP Right Cessation
- 2012-03-07 ZA ZA2012/01681A patent/ZA201201681B/en unknown
- 2012-03-07 TW TW101107763A patent/TWI428342B/zh not_active IP Right Cessation
- 2012-03-07 SA SA112330231A patent/SA112330231B1/ar unknown
- 2012-03-07 WO PCT/FR2012/000080 patent/WO2012120206A1/fr active Application Filing
- 2012-03-07 EP EP12290077.2A patent/EP2497774B1/fr active Active
- 2012-03-07 RU RU2013144824/04A patent/RU2572556C2/ru not_active IP Right Cessation
- 2012-03-07 SA SA112330331A patent/SA112330331B1/ar unknown
- 2012-03-07 US US13/413,977 patent/US8778932B2/en not_active Expired - Fee Related
- 2012-03-07 UA UAA201202760A patent/UA112153C2/uk unknown
- 2012-03-08 KR KR1020120023935A patent/KR101477991B1/ko active IP Right Grant
- 2012-03-08 GT GT201200066A patent/GT201200066A/es unknown
- 2012-03-08 CN CN201210063418.8A patent/CN102675341B/zh not_active Expired - Fee Related
- 2012-03-08 CU CUP2012000041A patent/CU24134B1/es unknown
-
2013
- 2013-03-18 HK HK13103337.1A patent/HK1176355A1/xx not_active IP Right Cessation
- 2013-12-13 CY CY20131101128T patent/CY1114729T1/el unknown
-
2014
- 2014-01-16 HR HRP20140050AT patent/HRP20140050T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20150045A (es) | Inhibidores de hepatitis c | |
ECSP099216A (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CR20140275A (es) | Triazolopiridinas sustituidas | |
EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
AR088226A1 (es) | Derivados piperidinicos heterociclicos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades neurodegenerativas | |
CU24030B1 (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen | |
CR20140135A (es) | Nuevos derivados de aril-quinolina | |
CU20100157A7 (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
AR085088A1 (es) | Inhibidores de histona desacetilasa y composiciones farmaceuticas que los contienen | |
EA201491276A1 (ru) | Новые производные бензилсульфонамида, подходящие для применения в качестве ингибиторов mogat-2 | |
CR20160030A (es) | Nuevos compuestos isoindolina o isoquinolina, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
BR112013005823B8 (pt) | Compostos heterocíclicos para o tratamento ou prevenção de distúrbios causados pela neurotransmissão reduzida de serotonina, norefnefrina ou dopamina | |
CU20120041A7 (es) | Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CU20130037A7 (es) | Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CR11566A (es) | Nuevos derivados cromenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
UY32702A (es) | Nuevos derivados de ácido 2-mercaptociclopentanocarboxílico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
UY33862A (es) | Nuevos compuestos de benzamida, composiciones agroquímicas que los contienen, procesos de preparación y usos? | |
SV2010003626A (es) | Nuevos compuestos piperidinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
CR11599A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR078181A1 (es) | Derivados acetilenicos de 5-fenilpirazolopiridina, su preparacion y su aplicacion terapeutica en enfermedades mediadas por los receptores nucleares nurr-1 | |
UY30343A1 (es) | Derivados de 1,2,3,4-tetrahidro-quinolina como inhibidores de cetp |